Crizotinib key intermediate

Min.Order / FOB Price:Get Latest Price

10 Gram	Negotiable

10 Gram

Negotiable

Min.Order :10 Gram
Purity: 99%
Payment Terms : L/C,T/T

Keywords

(S)-1-(2,6-Dichloro-3-fluorophenyl)ethanol Chiral Reactive Intermediate high purity stable process

Quick Details

Appearance:white solid
Application:Crizotinib key intermediate Antitumor drug intermediate
PackAge:standard package
ProductionCapacity:commercial production|Metric Ton|Day
Storage:room temperature
Transportation:Non-hazardous

Superiority:

Commercial production from grams to tons， with technical documents package support and audit/inspection support.

All the products we produced with high purity, optimized and stable process.

Details:

MW: 209.04

SENOVA PHARMA is committed to the development and production of API’s, advanced intermediates and biochemical products.

We insist on product development and production technology platform combining chemical synthesis (drug synthesis) technology, enzyme synthesis (biocatalytic and biotransformation) technology and microbial fermentation (biosynthesis) technology.

Our own production base and our cooperative plants in China produce products according to cGMP application, providing customers with stable and reliable whole-chain solutions.

View All